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Yukiko Goda and Manpreet Mutneja
A link between long-term potentiation (LTP) and
memory has been supported by learning defects
following treatments that impair LTP. Important new
evidence for the link comes from mutant mice lacking
the nociceptin receptor, which show improved learning
and memory accompanied by enhanced LTP.
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Long-term synaptic plasticity, in particular long-term
potentiation (LTP), has generated much interest as a
potential physiological substrate for certain types of
learning and memory [1]. Indeed, the discovery of LTP
has fuelled hopes that, before long, we may have a cellular
and molecular explanation for how we learn and remem-
ber things. While the molecular mechanisms of LTP are
becoming better understood, its precise role in memory
remains uncertain. Technical advances in molecular
biology over the last decade, however, have made it possi-
ble to look for correlated changes in LTP and behavior in
genetically modified mice, and brought memory research
into a new era.
Let us first briefly review why LTP is an attractive
candidate for being a physiological substrate of learning
and memory. LTP is a long-lasting enhancement in the
efficiency of synaptic communication between neurons,
and is induced by a repetitive and synchronous stimula-
tion of presynaptic cells. Such a stimulation fulfills the
special conditions required to activate the postsynaptic
N-methyl-D-aspartate (NMDA) subtype of glutamate
receptor. The activation of these receptors, in turn, lets
Ca2+ ions into the cell, initiating the Ca2+-dependent sig-
naling necessary for the expression of LTP. 
LTP has a number of distinguishing features. First, it is
robustly expressed in the hippocampus, a brain structure
known to be important for particular types of memory.
Second, like many forms of learning, LTP obeys the asso-
ciative principle. This principle is evident, for example, in
a type of learning referred to as sensory preconditioning,
in which animals learn to associate two different sensory
stimuli, such as pain and tone, after repeated pairing. The
associativity of LTP is thought to arise from its depen-
dency on NMDA receptors. This is because the binding
of glutamate to NMDA receptors and depolarization of
the postsynaptic membrane must occur simultaneously for
NMDA receptors to become active. And third, LTP is
quickly induced by a brief stimulation, is expressed for a
long time (weeks to months), and can be reversed. This is
much like memory, which forms quickly, lasts for a long
time, and can be erased.  The suggestion is that memory is
represented as stimulation-induced changes in neuronal
networks that are mediated by LTP.
The dependence of memory on LTP has been investi-
gated mainly in rodents. In such studies, the animals are
tested in memory tasks under conditions that inhibit LTP.
LTP is blocked either pharmacologically by injecting
NMDA receptor antagonists into the brain, or genetically
by creating transgenic mice or ‘knockout’ mice with tar-
geted mutations affecting proteins likely to be required
for LTP. The genetic approach has shown that the loss or
change in function of a variety of signaling molecules,
including serine/threonine and tyrosine kinases, results in
the inhibition of LTP and impairment of spatial learning.
Recent work by Takeshima and colleagues [2] adds a new
twist to the LTP–memory connection. In contrast to the
concurrent loss in LTP and memory observed in previous
work, the new study shows that, compared to wild-type
mice, mutant mice lacking the nociceptin receptor actu-
ally show increased LTP and have a better memory [2].
Nociceptin has primarily been implicated in nociception,
and a role for its receptor in learning and memory was
unexpected. The gene for the nociceptin receptor, from
its sequence a G-protein-coupled receptor, was cloned by
virtue of sequence similarity to the classical opioid recep-
tors, and found to be widely expressed in the brain and
spinal cord [3]. The nociceptin receptor was originally
called the ‘orphan’ opioid receptor because none of the
known opiates activated the receptor effectively. A search
for an endogenous agonist identified a heptadecapeptide,
named orphanin FQ by Reinscheid et al. [4], after the ter-
minal phenylalanine and glutamine residues that flank the
peptide, and nociceptin by Meunier et al. [5], as it causes
heightened sensitivity to pain when injected into the
mouse brain. Given the lack of a suitable inhibitor, the in
vivo function of the nociceptin receptor remained ambigu-
ous, despite the suggested role for its agonist in nocicep-
tion. To complicate matters further, mice lacking the
nociceptin receptor displayed nociceptive responses that
were seemingly indistinguishable from those observed in
wild-type mice [6].
Prompted by a lack of change in nociceptive properties of
the mutant mice, Manabe et al. [2] looked for involvement
of the nociceptin receptor in hippocampus-dependent
spatial learning, using the Morris water maze [2]. In this
experimental setup, a mouse must learn to find a hidden
platform in a circular swimming pool by using distal cues
in the room. Surprisingly, the mutant mice learned the
task faster during the first few trials than wild-type mice.
When tested over longer time periods, however, the two
groups reached the same level of performance. The
enhanced learning rate of the mutant mice was not due to
differences in locomotion or basic swimming abilities.
To find out more about the ability of the mutant mice to
learn and remember, they were tested on a passive avoid-
ance task. In this test, a mouse is placed in a cage consist-
ing of a light and a dark chamber. Although mice naturally
prefer the dark chamber, they learn to stay in the light
chamber as an electric shock is given upon entering the
dark side. Learning is indicated by the number of trials it
takes for the mice to stay at least two minutes in the light
side. After learning the task, memory retention is tested
by monitoring the latency for entering the dark chamber
— the longer the latency, the better their memory reten-
tion. Although the nociceptin receptor mutant mice
learned faster than wild-type mice in the water maze, the
rate of learning of the passive avoidance task was not sig-
nificantly different between the two groups. The mutant
mice did, however, display better memory retention than
the wild-type mice when tested at a later time.
Although the relative performances of the mutant and
wild-type mice were different for each task, overall the
mutant mice performed significantly better than the wild-
type mice. Furthermore, in a previous study, the noci-
ceptin receptor mutant mice displayed better memory
than wild-type mice in a spatial attention test [7]. This
evidence for enhanced memory in mice lacking the noci-
ceptin receptor indicates that the nociceptin receptor
pathway suppresses memory formation under normal con-
ditions. Consistent with this notion, spatial learning in rats
was found to be impaired when a nociceptin receptor
agonist — the nociceptin/orphanin FQ peptide — was
injected into the hippocampus [8].
The tasks on which the mutant mice showed a better-than
wild-type performance are known to test hippocampus-
dependent learning. The idea naturally arises that this
might reflect changes in properties of hippocampal cir-
cuits, in particular LTP, in the mutant mice. To investi-
gate this possibility, Manabe et al. [2] compared LTP in
hippocampal slices from wild-type and mutant mice.
Remarkably, the nociceptin receptor mutant mice
expressed a significantly larger LTP than control mice —
about a twofold increase in the extent of synaptic potenti-
ation over the baseline value. 
The parallel increase in learning/memory ability and LTP
in the nociceptin receptor mutants reinforces the assertion
that the mechanisms of LTP underlie learning and
memory. But while these findings support the
LTP–memory connection, some questions remain unan-
swered. For instance, the mechanism by which the noci-
ceptin receptor regulates LTP, the exact role of the
nociceptin receptor in memory, and the causal relationship
between LTP and memory all remain unknown. Let us
consider some possibilities.
What could the molecular basis be for the increased LTP
in the absence of the nociceptin receptor? The nociceptin
receptor ligand nociceptin/orphanin FQ has been reported
to promote conditions that inhibit neurotransmitter
release [3,9,10]. Nociceptin/orphanin FQ also blocks LTP
induction in the hippocampus, most likely by decreasing
synaptic transmission and/or NMDA receptor activation
[11]. In view of these negative regulatory effects of the
nociceptin receptor ligand, one might expect that the
increased LTP in the receptor mutant mice results from a
disinhibition of synaptic transmission and enhancement of
NMDA receptor activation. 
The electrophysiological properties of synapses in the
brains of the receptor mutant mice showed no obvious
abnormalities, however. More detailed analysis of synaptic
function may uncover some abnormalities, but normal
synaptic function would be expected if the endogenous
level of nociceptin/orphanin FQ is normally low. Endoge-
nous nociceptin/orphanin FQ may be released in suffi-
cient amounts to activate the nociceptin receptor only in
response to an LTP-inducing stimulus. To discover the
origin of the elevated LTP in the mutant mice, it may be
necessary to compare synapses under conditions that
permit LTP expression. Another possibility to consider is
that the increased LTP in the mutant mice is not a direct
result of absence of the nociceptin receptor, but rather is
due to developmental defects. The nociceptin receptor
might be required for normal development of hippocam-
pal circuits so that, in its absence, neuronal connectivity
patterns might be subtly altered in a way that is not appar-
ent by gross morphological examination.
If the nociceptin receptor really does function specifi-
cally in learning and memory, what precisely is its role?
One issue is the temporal phase of learning that is
affected by the absence of nociceptin receptor. As men-
tioned above, the two different experimental setups
implicated distinct aspects of learning and memory:
learning rate in the case of the water maze, and memory
retention in the case of the passive avoidance task. This
may reflect differences in the memory mechanisms
assayed by each behavioral task. The generation of con-
ditional mutant mice, in which the expression of genes
can be turned on and off, may allow a more precise defin-
ition of the phase of learning influenced by nociceptin
receptor function [12].
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Another outstanding issue is the generality of the require-
ment for nociceptin receptor function in various forms of
learning. The mutant mice showed improved learning and
memory in several different tasks, each of which is likely
to involve multiple cognitive processes [13,14]. The noci-
ceptin receptor could, therefore, be involved in a number
of brain functions, not limited to hippocampus-dependent
memory. The wide distribution of nociceptin receptor in
the nervous system [3] supports such a notion.
Will we ever be able to prove that LTP is a cellular
mechanism by which neural circuits encode information?
The evidence implicating LTP in learning and memory
connection is circumstantial, and the nociceptin receptor
study is no exception. The new results do show that
enhanced LTP can translate into a better memory, but is
LTP a sufficient indicator of memory? Perhaps other
forms of long-term synaptic plasticity, such as long-term
depression (LTD) which has also been implicated in hip-
pocampus-dependent memory [15], should be examined.
It is conceivable that LTD is also enhanced in the noci-
ceptin receptor mutants, particularly as the induction
mechanisms for LTP and LTD are known to have some
components in common. Alternatively, LTD might be
weakened in the mutant mice, facilitating the induction
and maintenance of the potentiated state, and this could
directly influence the learning ability of mutant mice.
Attempts to establish a connection between LTP and
memory will clearly benefit from an extensive inventory of
learning behaviors associated with various states of synap-
tic plasticity. Such information will provide a basis for for-
mulating a more precise model of the memory mechanism.
There are, however, more challenging tasks before us. It
will be important to show that long-lasting synaptic modi-
fications actually occur while an animal undergoes spatial
learning. And it should be possible to test whether artifi-
cial learning can be achieved by inducing specific synaptic
modifications in vivo. The good news is that a search for
nociceptin receptor antagonists may soon give us drugs
that directly enhance our own memories.
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